Literature DB >> 35747540

Confirming a Historical Diagnosis of Multiple Sclerosis: Challenges and Recommendations.

Andrew J Solomon1, Georgina Arrambide1, Wallace Brownlee1, Anne H Cross1, María I Gaitan1, Fred D Lublin1, Naila Makhani1, Ellen M Mowry1, Daniel S Reich1, Àlex Rovira1, Brian G Weinshenker1, Jeffrey A Cohen1.   

Abstract

Patients with a historical diagnosis of multiple sclerosis (MS)-a patient presenting with a diagnosis of MS made previously and by a different clinician-present specific diagnostic and therapeutic challenges in clinical practice. Application of the McDonald criteria is most straightforward when applied contemporaneously with a syndrome typical of an MS attack or relapse; however, retrospective application of the criteria in some patients with a historical diagnosis of MS can be problematic. Limited patient recollection of symptoms and evolution of neurologic examination and MRI findings complicate confirmation of an earlier MS diagnosis and assessment of subsequent disease activity or clinical progression. Adequate records for review of prior clinical examinations, laboratory results, and/or MRI scans obtained at the time of diagnosis or during ensuing care may be inadequate or unavailable. This article provides recommendations for a clinical approach to the evaluation of patients with a historical diagnosis of MS to aid diagnostic confirmation, avoid misdiagnosis, and inform therapeutic decision making.
© 2022 American Academy of Neurology.

Entities:  

Year:  2022        PMID: 35747540      PMCID: PMC9208427          DOI: 10.1212/CPJ.0000000000001149

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  30 in total

1.  Challenges in multiple sclerosis diagnosis: Misunderstanding and misapplication of the McDonald criteria.

Authors:  Andrew J Solomon; Roman Pettigrew; Robert T Naismith; Salim Chahin; Stephen Krieger; Brian Weinshenker
Journal:  Mult Scler       Date:  2020-03-12       Impact factor: 6.312

2.  Progress towards a diagnostic biomarker for MS: Central vein sign.

Authors:  Andrew J Solomon
Journal:  Mult Scler       Date:  2020-04       Impact factor: 6.312

3.  Differential diagnosis of suspected multiple sclerosis: a consensus approach.

Authors:  D H Miller; B G Weinshenker; M Filippi; B L Banwell; J A Cohen; M S Freedman; S L Galetta; M Hutchinson; R T Johnson; L Kappos; J Kira; F D Lublin; H F McFarland; X Montalban; H Panitch; J R Richert; S C Reingold; C H Polman
Journal:  Mult Scler       Date:  2008-09-19       Impact factor: 6.312

4.  The central vein sign in multiple sclerosis patients with vascular comorbidities.

Authors:  François Guisset; Valentina Lolli; Céline Bugli; Gaetano Perrotta; Julie Absil; Bernard Dachy; Caroline Pot; Marie Théaudin; Marco Pasi; Vincent van Pesch; Pietro Maggi
Journal:  Mult Scler       Date:  2020-08-04       Impact factor: 6.312

5.  Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.

Authors:  Mark P Gorman; Brian C Healy; Mariann Polgar-Turcsanyi; Tanuja Chitnis
Journal:  Arch Neurol       Date:  2009-01

6.  Long-term disability progression of pediatric-onset multiple sclerosis.

Authors:  Kyla A McKay; Jan Hillert; Ali Manouchehrinia
Journal:  Neurology       Date:  2019-05-15       Impact factor: 9.910

7.  "Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study.

Authors:  Massimiliano Calabrese; Claudio Gasperini; Carla Tortorella; Gianmarco Schiavi; Giovanni Frisullo; Paolo Ragonese; Roberta Fantozzi; Luca Prosperini; Pietro Annovazzi; Cinzia Cordioli; Massimiliano Di Filippo; Diana Ferraro; Alberto Gajofatto; Simona Malucchi; Salvatore Lo Fermo; Giovanna De Luca; Maria L Stromillo; Eleonora Cocco; Antonio Gallo; Damiano Paolicelli; Roberta Lanzillo; Valentina Tomassini; Ilaria Pesci; Maria E Rodegher; Claudio Solaro
Journal:  Neurology       Date:  2019-05-01       Impact factor: 9.910

8.  Multiple sclerosis diagnosis: Knowledge gaps and opportunities for educational intervention in neurologists in the United States.

Authors:  Andrew J Solomon; Marwa Kaisey; Stephen C Krieger; Salim Chahin; Robert T Naismith; Sarah M Weinstein; Russell T Shinohara; Brian G Weinshenker
Journal:  Mult Scler       Date:  2021-10-06       Impact factor: 5.855

9.  Defining the clinical course of multiple sclerosis: the 2013 revisions.

Authors:  Fred D Lublin; Stephen C Reingold; Jeffrey A Cohen; Gary R Cutter; Per Soelberg Sørensen; Alan J Thompson; Jerry S Wolinsky; Laura J Balcer; Brenda Banwell; Frederik Barkhof; Bruce Bebo; Peter A Calabresi; Michel Clanet; Giancarlo Comi; Robert J Fox; Mark S Freedman; Andrew D Goodman; Matilde Inglese; Ludwig Kappos; Bernd C Kieseier; John A Lincoln; Catherine Lubetzki; Aaron E Miller; Xavier Montalban; Paul W O'Connor; John Petkau; Carlo Pozzilli; Richard A Rudick; Maria Pia Sormani; Olaf Stüve; Emmanuelle Waubant; Chris H Polman
Journal:  Neurology       Date:  2014-05-28       Impact factor: 9.910

10.  Lesion topographies in multiple sclerosis diagnosis: A reappraisal.

Authors:  Georgina Arrambide; Mar Tintore; Cristina Auger; Jordi Río; Joaquín Castilló; Angela Vidal-Jordana; Ingrid Galán; Carlos Nos; Manuel Comabella; Raquel Mitjana; Patricia Mulero; Andrea de Barros; Breogán Rodríguez-Acevedo; Luciana Midaglia; Jaume Sastre-Garriga; Alex Rovira; Xavier Montalban
Journal:  Neurology       Date:  2017-11-03       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.